1 篇已发布文章 · DVN
Vinapharm (DVN) reports record pre-tax profit of 825 billion VND in 2025, up 62% YoY. AGM approves 10% cash dividend and strategy on biosimilars and technology transfer.
所有信息仅供参考,不构成投资建议。过往表现不代表未来收益。数据来源于越南公开市场信息。
最后更新: 2026-04-24T18:25:29.081286.
About · Methodology